House to hold CDMRP hearing, including prostate cancer testimony


The Appropriations Defense subcommittee of the U.S. House of Representatives is to convene a hearing tomorrow (May 20, 2010), featuring public testimony regarding prostate cancer research within the Congressionally Directed Medical Research Program (CDMRP). The hearing will be held at 10:00 am in room H-140 of the U.S. Capitol.

Sherry Galloway, RN and Jonathon W. Simons, MD will make the case for increased research funding for the Prostate Cancer Research Program. Ms Galloway is a registered nurse and board member of ZERO — The Project to End Prostate Cancer. She has had an intimate experience with prostate cancer as her husband is a 6-year survivor and her son died with advanced, metastatic prostate cancer at the age of just 36.  Dr. Simons is the CEO and president of the Prostate Cancer Foundation. He will present testimony focusing on the scientific needs of the prostate cancer community.

It is, of course, a great pity that this information was only released for public consumption 24 hours or so prior to the actual hearing. However, the fact that there will be a hearing at all, and that two witnesses will be able to give testimony related to the CDMRP Prostate Cancer Research Program, are some recognition for all the effort that has been made by the advocacy community to increase funding for this specific research initiative.

One Response

  1. A lot of us will be there in spirit, regretting that the very short notice precludes attendance and support.

    Dr. Simons and Ms. Galloway will be a fine representatives.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: